News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Giuseppe Banna: Enjoyed being part of the EAU 2025 Symposium
Giuseppe Banna/LinkedIn
Mar 24, 2025, 09:15

Giuseppe Banna: Enjoyed being part of the EAU 2025 Symposium

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on LinkedIn:

“I truly enjoyed being part of this insightful symposium with Verane Achard, Teresa Lopez, and Alberto Briganti at EAU25, discussing relugolix, an LHRH antagonist with lower cardiovascular risk and rapid, profound castration and PSA decline.

It makes a valuable option in metastatic hormone-sensitive prostate cancer (mHSPC), particularly in the context of treatment de-escalation strategies. – Giuseppe Banna

Great discussions and perspectives – looking forward to continuing the conversation!”

Giuseppe Banna

Alberto Briganti cancer cardiovascular risk EAU25 Giuseppe Banna Metastatic Hormone-sensitive Prostate Cancer OncoDaily Oncology prostate cancer Teresa Lopez Verane Achard
Special Coverage
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer